Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1983-6-10
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0160-2446
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
341-2
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:6188913-Adult,
pubmed-meshheading:6188913-Aged,
pubmed-meshheading:6188913-Bezafibrate,
pubmed-meshheading:6188913-Clofibrate,
pubmed-meshheading:6188913-Clofibric Acid,
pubmed-meshheading:6188913-Electrocardiography,
pubmed-meshheading:6188913-Female,
pubmed-meshheading:6188913-Humans,
pubmed-meshheading:6188913-Hypolipidemic Agents,
pubmed-meshheading:6188913-Male,
pubmed-meshheading:6188913-Middle Aged
|
pubmed:articleTitle |
Bezafibrate does not influence the QT interval in man.
|
pubmed:publicationType |
Letter
|